Cite

    Zhang, N. et al. (2023). An artificial intelligence network‐guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms. Cell proliferation. 56 (4), p. n/a. [Online].